Basic info
Industry
biotechnology research
Sectors
single B cell
High throughput
Biotechnology
Infectious disease
Human antibodies
Antibody discovery
Antibody repertoire
Collaboration
antibodyome
Therapeutic antibodies
Date founded
2012
Funding rounds raised
Total raised
$25M
from 11 investors over 11 rounds
M
Memo Therapeutics AG raised $25M on February 16, 2022
Investors: Zürcher Kantonalbank, Fresenius Medical Care, Vesalius Biocapital and Adjuvant Capital
M
Memo Therapeutics AG raised $11M on December 13, 2021
Investors: Bundesamt für Gesundheit
M
Memo Therapeutics AG raised $16M on November 6, 2020
Investors: Redalpine
M
Memo Therapeutics AG raised $5M on May 9, 2018
Investors: Zürcher Kantonalbank and Redalpine
M
Memo Therapeutics AG raised $2.3M on July 22, 2015
Investors: Redalpine, Zürcher Kantonalbank and EVA - the Basel start-up agency